User menu

Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.

Bibliographic reference Torres, Vicente E ; Chapman, Arlene B ; Devuyst, Olivier ; Gansevoort, Ron T ; Perrone, Ronald D ; et. al. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.. In: Nephrology, Dialysis, Transplantation, Vol. 32, no. 7, p. 1262 (2017)
Permanent URL http://hdl.handle.net/2078/187226